bamethan has been researched along with Intracranial Arteriosclerosis in 1 studies
bamethan: was heading 1963-94; BUTYLNORSYNEPHRIN was see BAMETHAN 1977-94; use ETHANOLAMINES to search BAMETHAN 1966-94
Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GUARESCHI, A | 1 |
| MONTANINI, R | 1 |
1 other study available for bamethan and Intracranial Arteriosclerosis
| Article | Year |
|---|---|
[Experimental research and clinical observations on the action of Vasculat in neuropsychiatry].
Topics: Cerebrovascular Disorders; Ethanolamines; Headache; Humans; Intracranial Arteriosclerosis; Neuropsyc | 1962 |